Zbigniew Darzynkiewicz

Changes in cell nuclei during S phase: progressive chromatin condensation and altered expression of the proliferation-associated nuclear proteins Ki-67, cyclin (PCNA), p105, and p34.

K. Bauer, H. Crissman, Z. Darżynkiewicz, 1991, Experimental cell research.

Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.

Z. Darżynkiewicz, G. Del Bino, M. Hotz, 1992, Cancer research.

Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.

Z. Darżynkiewicz, G. Del Bino, G. Bino, 1991, Cancer research.

Cell cycle-specific effects of lovastatin.

Z. Darżynkiewicz, S. Bruno, M. Jakóbisiak, 1991, Proceedings of the National Academy of Sciences of the United States of America.

2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor.

Z. Darżynkiewicz, X. Li, H. Halicka, 1995, Cancer research.

Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.

Z. Darżynkiewicz, S. Bruno, F. Traganos, 1992, Cancer research.

Apoptotic death of lymphocytes upon treatment with 2-chloro-2'-deoxyadenosine (2-CdA).

Z. Darżynkiewicz, P. Lassota, Z. Kazimierczuk, 1994, Archivum immunologiae et therapiae experimentalis.

Cytostatic and Cytotoxic Effects of Pannon (P‐30 Protein), A Novel Anticancer Agent

W. Ardelt, Z. Darżynkiewicz, S. Mikulski, 1988, Cell and tissue kinetics.

Intercalating agents with covalent bond forming capability. A novel type of potential anticancer agents. 2. Derivatives of chrysophanol and emodin.

T R Kelly, T. Chou, Z. Darżynkiewicz, 1989, Journal of medicinal chemistry.